Ballabgarh in north Indian state of Haryana could come up in the world map for an altogether new reason: The village has perhaps the lowest number of Alzheimer's disease risk in the world, according to a report.
US FDA has asked Daiichi-controlled Ranbaxy to undertake concrete steps to ensure that all of the company's facilities involved in manufacturing products to US market confirm with the regulator's cGMP requirements.
Palomid 529 (P529), an experimental therapy to treat age-related macular degeneration, has been entered into the first-in-man studies, Paloma Pharmaceuticals, Inc. announced.
Fidaxomicin, an experimental antibiotic to treat Clostridium difficile Infection (CDI), has been shown safe and effective in comparative studies with Vancocin, Optimer Pharmaceuticals, Inc announced.
Bayer Healthcare has joined hand with India's Biocon self-monitoring blood glucose meter Breeze2 in India.